Winship Melanoma & Cutaneous Oncology Symposium 2024 The Winship Cancer Institute Melanoma and Cutaneous Oncology Symposium serve as a valuable forum for the presentation and discussion of newly available data. Participants will be provided with an update on practice-changing data in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients with melanoma and non-melanoma skin cancer.
TARGET AUDIENCE
This activity is specifically designed to meet the needs of dermatologists, medical, surgical, and radiation oncologists, hematologists, residents, fellows, advanced practice providers, nurses, and pharmacists.
CONTINUING EDUCATION CREDIT
The Emory University School of Medicine designates this live activity for a maximum of 6.5 hours.
The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
LEARNING OBJECTIVES
After successful completion of this educational activity, participants should be able to:
- Identify recent advances and current status of neoadjuvant and adjuvant treatment of melanoma
- Discuss recent advances in surgical management of the nodal basin in melanoma
- Describe pathologic evaluation of pigmented lesions and regional lymph nodes, including evaluation of nodes after neoadjuvant treatment
- Discuss new insights into melanoma and detection and prevention
- Discuss current approaches to management of non-melanoma skin cancers
- Describe approaches to treatment of anti-PD-1 refractory melanoma
- Describe recent approaches to multidisciplinary management of Merkel cell carcinoma
COURSE DIRECTORS
- David H. Lawson, MD, Winship Cancer Institute of Emory University
- Michael Lowe, MD, MA, Winship Cancer Institute of Emory University
Topics:
- Agenda.pdf
SESSION 1- ADVANCES IN MANAGEMENT ADVANCED RESECTABLE MELANOMA Surgical Approaches to Nodal Basin Management in Melanoma.mp4
SESSION 1- ADVANCES IN MANAGEMENT ADVANCED RESECTABLE MELANOMA Updates in Neoadjuvant Therapies for Advanced Resectable Melanoma.mp4
SESSION 2- MULTIDISCIPLINARY MANAGEMENT OF CUTANEOUS MALIGNANCIES Pathologic Evaluation of Pigmented Lesions and Lymph Nodes.mp4
SESSION 2- MULTIDISCIPLINARY MANAGEMENT OF CUTANEOUS MALIGNANCIES Updates in Melanoma Prevention and Detection.mp4
SESSION 2- MULTIDISCIPLINARY MANAGEMENT OF CUTANEOUS MALIGNANCIES Using Gene Expression Profiling to Risk-Stratify Cutaneous Melanoma.mp4
TUMOR BOARD DISCUSSIONS Advanced Cutaneous Basal and Squamous Cell Carcinoma 1.mp4
TUMOR BOARD DISCUSSIONS Advanced Cutaneous Basal and Squamous Cell Carcinoma 2.mp4
TUMOR BOARD DISCUSSIONS Advanced Cutaneous Basal and Squamous Cell Carcinoma 3.mp4
TUMOR BOARD DISCUSSIONS Difficult Pigmented Lesions 1.mp4
TUMOR BOARD DISCUSSIONS Difficult Pigmented Lesions 2.mp4
TUMOR BOARD DISCUSSIONS Merkel Cell Carcinoma 1.mp4
TUMOR BOARD DISCUSSIONS Merkel Cell Carcinoma 2.mp4
TUMOR BOARD DISCUSSIONS Merkel Cell Carcinoma 3.mp4
TUMOR BOARD DISCUSSIONS Treatment Na‹ve and PD-1 Refractory stage IV Melanoma 1.mp4
TUMOR BOARD DISCUSSIONS Treatment Na‹ve and PD-1 Refractory stage IV Melanoma 2.mp4
TUMOR BOARD DISCUSSIONS Treatment Na‹ve and PD-1 Refractory stage IV Melanoma 3.mp4
Related products
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
